A new anti-MRSA antibiotic complex, WAP-8294A. I. Taxonomy, isolation and biological activities

J Antibiot (Tokyo). 1998 Oct;51(10):929-35. doi: 10.7164/antibiotics.51.929.

Abstract

WAP-8294A, produced by Lysobacter sp., is a complex consisting of water soluble depsipeptide antibiotics. It was further purified by column chromatographies and HPLC, and 19 components were obtained. WAP-8294A2, a major component, and minor components A1, A4, Ax8, Ax9 and Ax13 were active against gram-positive bacteria, in particular, methicillin-resistant Staphylococcus aureus (MRSA) in vitro. WAP-8294A2 was highly active in vivo in mice against the systemic infection of MRSA.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / isolation & purification*
  • Anti-Bacterial Agents / pharmacology
  • Depsipeptides*
  • Fermentation
  • Fungi / drug effects
  • Gram-Negative Bacteria / chemistry*
  • Gram-Negative Bacteria / classification
  • Gram-Negative Bacteria / drug effects
  • Gram-Positive Bacteria / drug effects
  • Inhibitory Concentration 50
  • Leukemia L1210 / pathology
  • Macrolides
  • Magnetic Resonance Spectroscopy
  • Male
  • Mass Spectrometry
  • Methicillin Resistance
  • Mice
  • Mice, Inbred ICR
  • Microbial Sensitivity Tests
  • Peptides, Cyclic / chemistry
  • Peptides, Cyclic / isolation & purification
  • Peptides, Cyclic / pharmacology
  • Staphylococcal Infections / drug therapy
  • Staphylococcus aureus / drug effects*
  • Tumor Cells, Cultured

Substances

  • Anti-Bacterial Agents
  • Depsipeptides
  • Macrolides
  • Peptides, Cyclic
  • lotilibcin